Apurva Dhupkar

Associate Scientist at Stratus Therapeutics

Apurva Dhupkar has a diverse work experience history. In 2014, they worked as a Summer Intern at the Indian Institute of Science. From 2017 to 2021, they worked as a Clinical Laboratory Scientist at Biosciences Clinic, where they were involved in the manufacturing process of extracting mesenchymal stem cells from adipose tissue for various aesthetic treatments. In 2021, they became a Research Assistant at the University of Southern California, volunteering at the Jadhav lab and assisting in laboratory experiments related to epigenetic changes. In 2022, they joined Jounce Therapeutics, Inc. as a Senior Research Associate, before moving on to their current role as an Associate Scientist at Garuda Therapeutics in 2023.

Apurva Dhupkar holds a Master's degree in Stem cell biology and Regenerative Medicine from the Keck School of Medicine of the University of Southern California, obtained from 2021 to 2022. They also possess a Bachelor of Science (B.Sc.) degree in Microbiology, General, acquired from Fergusson College between 2013 and 2015. Additionally, Apurva Dhupkar pursued a Master's degree in Genetics and Molecular Biology at Manipal University, Dubai, from 2015 to 2017.

Location

Boston, United States

Links

Previous companies


Org chart

This person is not in the org chart


Teams


Offices


Stratus Therapeutics

4 followers

Stratus Therapeutics is redefining regenerative medicine with Stratus Prime™ — a platform for full hematopoietic system renewal, on demand. Our proprietary product, ST-101, includes both hematopoietic stem cells (Prime HSCs™) and hematopoietic progenitor cells (Prime HPCs™) to drive durable, long-term engraftment with full hematopoietic system restoration, while supporting near-term immune reconstitution.


Employees

51-200

Links